Clinical Trials Browser

Phase 2 × Neuroendocrine Tumors × TIC10 compound × Clear all

NCT03034200 2024-11-26

Phase 2 Study of ONC201 in Neuroendocrine Tumors

Phase 2 Completed

30 enrolled 12 charts

Neuroendocrine Tumors